clinical trials for tg4010 & tg4040

Completed or ongoing FDA Clinical Trial Studies for TG4010 & TG4040

Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Biological: MVA-MUC1-IL2

http://clinicaltrials.gov/ct2/show/NCT00415818?term=TG4010&rank=1

Vaccine Therapy in Treating Patients With Advanced Cancer Condition: Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Biological: TG4010

http://clinicaltrials.gov/ct2/show/NCT00004881?term=TG4010&rank=2



Efficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV Patients Condition: Chronic Hepatitis C Infection
Interventions: Drug: pegylated interferon and ribavirin; Biological: TG4040 + SOC

http://clinicaltrials.gov/ct2/show/NCT01055821?term=TG4040&rank=2

Immunotherapy With TG4040 in Treatment-na?ve Patients Chronically Infected With Hepatitis C Virus Condition: Hepatitis C, Chronic
Intervention: Biological: MVA-HCV (Immunotherapy)

http://clinicaltrials.gov/ct2/show/NCT00529321?term=TG4040&rank=3